Peanut formulations and uses thereof
US12016917B2 · kind B2 · utility
0Cited by
22References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 7, 2020 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Jul 8, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.